Very disappointed as this has such potential and could be trading at dollars easily if management gave shareholders a reason to believe they would benefit people other than the mother ship (China)...
The potential has never changed and in fact its got considerably better, the main reason GRR hasn't attracted a lot of attention in the past is because its growth path was limited largely by the cash involved to grow, that now has the potential to change....the mothership is the reason we are in such a healthy financial position and has benefited all longer term shareholders.
The chart below is whats behind most of the angst around here and is why management are putting cash preservation for future growth ahead of splashing it out on large dividends , the cash windfall was a one off so needs to be taken advantage of , not all times will be as good as the last year or two, so get in position for the next cycle with more production....often known as common sense...
If IO stayed at $225 t forever life would be very good but with a chart like that it was never going to happen, very similar to GRR 's chart as one would expect. Unfortunately the Dow Jones chart is starting to have a similar upslope.
Cheers Whisky
- Forums
- ASX - By Stock
- GRR
- Ann: Dividend/Distribution - GRR
Ann: Dividend/Distribution - GRR, page-267
Featured News
Add GRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $283.5M |
Open | High | Low | Value | Volume |
24.0¢ | 25.0¢ | 24.0¢ | $82.16K | 334.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 128010 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 82539 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 128010 | 0.245 |
10 | 218024 | 0.240 |
13 | 418757 | 0.235 |
25 | 759497 | 0.230 |
13 | 1096732 | 0.225 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 77539 | 8 |
0.255 | 366545 | 9 |
0.260 | 285500 | 9 |
0.265 | 206125 | 8 |
0.270 | 354430 | 8 |
Last trade - 12.40pm 12/11/2024 (20 minute delay) ? |
Featured News
GRR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online